Drug recall issued after possible carcinogen contamination

11:27 AM, Nov 13, 2018

Contamination concerns have prompted the Food and Drug Administration to issue a voluntary recall on a widely used blood pressure medication.

Sandoz, the pharmaceutical company that makes the drug Losartan, announced the recall after trace amounts of a possible cancer causing chemical were found.

The recall applies only to 100 milligram/25 milligram tablets of the drug with a Lot number of JB8912, distributed after October 8, 2018.

To date, the manufacturer says it has not received any reports of adverse effects related to the recalled medication.

Anyone with questions regarding this recall can contact Sandoz Inc. at 1-800-525-8747 Monday-Friday 8:30 a.m. – 5 p.m. (EST) or email usdrugsafety.operations@novartis.com.

Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.

About Brand Spotlight

Brand Spotlight offers useful, valuable information from select sponsors on these pages. This content is not produced or endorsed by this station.